Marisa Taylor is a senior correspondent on the KHN enterprise team. She investigates end-of-life care and acute medical care, among other health care topics.
Marisa Taylor
From this contributor
Immigrant children detained in U.S. may struggle to get health care
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
3 July 2018 | 5 min read
Thousands of children younger than 13 detained under U.S. border policy
The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown.
Thousands of children younger than 13 detained under U.S. border policy
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
22 June 2018 | 6 min read
Federal limits on medical marijuana research hinder treatments
By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.
Federal limits on medical marijuana research hinder treatments
By
Melissa Bailey, Marisa Taylor, Kaiser Health News
16 April 2018 | 9 min read
Trading controversy dogs health secretary nominee Tom Price
U.S. Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading, despite the fact that a House committee he was on was under investigation.
Trading controversy dogs health secretary nominee Tom Price
By
Marisa Taylor, Christina Jewett, Kaiser Health News
9 February 2017 | 7 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read